Suwa Lal Jat
About Suwa Lal Jat
Data last updated:
Suwa Lal Jat is a Director at Cris Pharma (India) Limited (since 2011) and Director at Novelsort Lifecare Private Limited (since 2016). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹57.54 Cr; the largest is Cris Pharma (India) Limited at ₹55.24 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cris Pharma (India) Limited U24139RJ1992PLC034757 | Director | 25 Jul 2011 | 1992 | ₹55.24 Cr (FY 2024) | Active |
 Novelsort Lifecare Private Limited U74999RJ2016PTC056205 | Director | 14 Oct 2016 | 2016 | ₹2.31 Cr (FY 2025) | Active |
Board colleagues of Suwa Lal Jat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kailash Chand Melana | 00598374 | Cris Pharma (India) Limited | Director |
| Poonam Chand Taparia | 00598323 | Cris Pharma (India) Limited | Whole-Time Director |
| Manish Natwadia | 09059189 | Novelsort Lifecare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suwa Lal Jat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suwa Lal Jat
Suwa Lal Jat currently holds 2 directorships: Cris Pharma (India) Limited (Director, since 25 Jul 2011, revenue ₹55.24 Cr (FY 2024)); Novelsort Lifecare Private Limited (Director, since 14 Oct 2016, revenue ₹2.31 Cr (FY 2025)).
Suwa Lal Jat was first appointed on 25 Jul 2011 as Director at Cris Pharma (India) Limited. The most recent appointment on record is 14 Oct 2016 at Novelsort Lifecare Private Limited.
The 2 current companies of Suwa Lal Jat that report revenue have a combined latest revenue of ₹57.54 Cr: Cris Pharma (India) Limited ₹55.24 Cr (FY 2024); Novelsort Lifecare Private Limited ₹2.31 Cr (FY 2025).
The current boards of Suwa Lal Jat's companies include Kailash Chand Melana (Cris Pharma (India) Limited), Poonam Chand Taparia (Cris Pharma (India) Limited), Manish Natwadia (Novelsort Lifecare Private Limited).